生物股份(600201.SH):子公司金宇保靈、揚州優邦獲得獸藥生產許可證和獸藥GMP證書
格隆匯12月24日丨生物股份(600201.SH)公佈,近期,公司全資子公司金宇保靈生物藥品有限公司(“金宇保靈”)收到內蒙古自治區農牧廳核發的《獸藥生產許可證》和《獸藥GMP證書》,全資子公司揚州優邦生物藥品有限公司(“揚州優邦”)收到江蘇省農業農村廳核發的《獸藥生產許可證》和《獸藥GMP證書》。
金宇保靈本次依據《獸藥管理條例》和《獸藥生產質量管理規範(2020年修訂)》新增通過認證的項目為細胞懸浮培養病毒滅活疫苗(含細胞懸浮培養病毒亞單位疫苗)生產線、梭菌滅活疫苗(含乾粉製品)生產線和細菌活疫苗生產線。
揚州優邦本次依據《獸藥管理條例》和《獸藥生產質量管理規範(2020年修訂)》通過認證的項目為細胞培養病毒滅活疫苗生產線、細胞懸浮培養病毒亞單位疫苗生產線、胚培養病毒滅活疫苗生產線、細菌培養亞單位疫苗生產線、細胞培養病毒活疫苗生產線。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.